We believe that scientific and commercial partnerships will contribute to our ability to rapidly advance.

Collaborations are important elements of our strategy (to build an independent oncology company). We believe that scientific and commercial partnerships will contribute to our ability to rapidly advance our therapeutic product candidates, build out our product platform and progress a wide range of discovery and development programs.

If you are interested in working with us, please contact us through  .

We are collaborating with Sidney Kimmel Cancer Center to evaluate safety and efficacy of Imvax proprietary personalized immunotherapy in malignant gliomas.